Stock listing

NASDAQ:ERNA Ernexa Therapeutics Inc. Stock

Home listing (NASDAQ) of Ernexa Therapeutics Inc.

Follow Ernexa Therapeutics Inc. into a list and get an email when it puts out news.

Share price · NASDAQ:ERNA

$1.36 USD -0.26 (-16.0%)

Close on Nov 20, 2026

Past year -95.8% · daily closes, Nov 20, 2025 – Nov 20, 2026, adjusted for splits
Day range
$1.35 – $1.60 USDNov 20, 2026
Volume
20,382 sharesNov 20, 2026
Market cap
$2.30M USDAt the close on Nov 20, 2026 · price × 1.69M shares outstanding
52-week range
$1.35 – $37.50 USDLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
Traded on an average day
$140,241 USDMedian day 20,382 shares · last 3 months, Aug 20, 2026 – Nov 20, 2026
Ernexa Therapeutics Inc. logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
NASDAQ:ERNA · Home$1.36 USD-0.26 (-16.0%)20,382$1.60$1.60$1.35$1.62Close on Nov 20, 2026

Daily closes

Last 3 months, Aug 20, 2026 – Nov 20, 2026 · NASDAQ:ERNA · USD, adjusted for splits

DayCloseChange%OpenHighLowVolume
$1.36-0.26-16.0%$1.60$1.60$1.3520,382
$1.62-0.01-0.6%$1.64$1.713$1.6014,752
$1.63-0.06-3.6%$1.65$1.822$1.5726,221
$1.69+0.01+0.6%$1.80$1.80$1.6920,359
$1.68-0.11-6.1%$1.82$1.94$1.6728,254
$1.79-0.14-7.3%$1.87$2.04$1.73423,989
$1.93-0.08-4.0%$2.053$2.053$1.909,815
$2.01-0.04-2.0%$1.98$2.04$1.9013,321
$2.05+0.17+9.0%$1.87$2.05$1.75528,402
$1.88+0.05+2.7%$1.78$1.895$1.787,913
$1.83-0.16-8.0%$2.05$2.05$1.7433,732
$1.99-0.03-1.5%$1.98$2.04$1.9417,332
$2.02+0.07+3.6%$2.075$2.123$1.9911,368
$1.95-0.02-1.0%$2.04$2.04$1.938,999
$1.97-0.14-6.6%$2.08$2.14$1.954,493
$2.11+0.13+6.6%$2.03$2.11$1.9987,265
$1.98-0.013-0.7%$1.91$2.03$1.913,471
$1.993+0.055+2.8%$2.12$2.12$1.967,436
$1.938-0.127-6.2%$1.98$2.08$1.9211,182
$2.065-0.01-0.5%$2.075$2.09$2.035,931
$2.075-0.035-1.7%$2.095$2.125$1.9816,467
$2.11-0.13-5.8%$2.19$2.255$2.089,569
$2.24+0.26+13.1%$1.96$2.26$1.8948,186
$1.98-0.11-5.3%$2.04$2.07$1.83944,353
$2.09-0.08-3.7%$2.17$2.23$2.0424,617
$2.17+0.06+2.8%$2.10$2.23$2.057,004
$2.11-0.10-4.5%$2.20$2.20$2.01310,300
$2.210.000.0%$2.19$2.24$2.188,312
$2.21-0.19-7.9%$2.40$2.40$2.12530,705
$2.40-0.09-3.6%$2.45$2.49$2.2546,599
$2.49+0.10+4.2%$2.40$2.70$2.12214,740
$2.39+0.155+6.9%$2.25$2.39$2.15662,923
$2.235-0.465-17.2%$2.75$2.96$2.2091,550
$2.70-0.26-8.8%$3.04$3.058$2.7021,552
$2.960.000.0%$3.00$3.28$2.9040,810
$2.96-0.24-7.5%$3.13$3.236$2.8435,741
$3.20+0.04+1.3%$3.24$3.47$3.1642,635
$3.16-0.31-8.9%$3.738$3.738$3.04461,865
$3.47+0.025+0.7%$3.46$3.50$3.2025,791
$3.445-0.175-4.8%$3.73$3.848$3.4021,417
$3.62-0.03-0.8%$3.785$3.821$3.6111,526
$3.65-0.15-3.9%$3.73$3.79$3.656,237
$3.80-0.16-4.0%$3.96$3.96$3.7614,663
$3.96+0.13+3.4%$4.01$4.01$3.7513,500
$3.83+0.07+1.9%$3.79$3.885$3.798,276
$3.76-0.15-3.8%$4.04$4.08$3.71533,601
$3.91-0.17-4.2%$4.01$4.155$3.8422,562
$4.08-0.19-4.4%$3.79$4.70$3.65547,184
$4.27+0.105+2.5%$4.13$4.40$4.1316,826
$4.165+0.145+3.6%$4.05$4.42$4.0319,816
$4.020.000.0%$3.925$4.05$3.9011,381
$4.02-0.17-4.1%$4.20$4.23$3.9715,648
$4.19-0.12-2.8%$4.31$4.34$4.1318,298
$4.31-0.22-4.9%$4.50$4.83$4.2147,568
$4.53-0.01-0.2%$4.494$4.728$4.4014,673
$4.54+0.19+4.4%$4.42$4.804$4.4023,297
$4.35-0.22-4.8%$4.57$4.65$4.2629,517
$4.570.000.0%$4.68$4.75$4.549,638
$4.57-0.165-3.5%$4.76$4.99$4.5626,720
$4.735-0.155-3.2%$4.77$4.93$4.5641,081
$4.89-0.035-0.7%$4.82$4.932$4.7515,092
$4.925-0.11-2.2%$5.00$5.51$4.89481,862
$5.035+0.175+3.6%$4.86$5.15$4.7522,643
$4.86+0.34+7.5%$4.53$5.198$4.5371,125
$4.52+0.09+2.0%$4.34$4.76$4.3427,832

Splits

4 splits since 2021 · NASDAQ:ERNA · every price before a split is adjusted for it

DayRatioWhat
1-for-25Consolidation
1-for-15Consolidation
1-for-20Consolidation
1-for-2Consolidation
Ticker
NASDAQ:ERNA
Asset type
Stock
Sector
Health care
Industry
Biotechnology
Exchange
NASDAQ
Currency
USD

What changed lately

Latest news

All Ernexa Therapeutics Inc. news

Financings

  • Public offering of shares of common stock (or common stock equivalents) and accompanying warrants

    Feb 6, 2026

    Announced: about US$10.5M · US$0.5 a share · Warrants at US$0.68 · Brookline Capital Markets, a division of Arcadia Securities, LLC

    Dealers: Brookline Capital Markets, a division of Arcadia Securities, LLC (lead)

    Use of proceeds: Advancement of its development programs, working capital and general corporate purposes

    Announced Feb 6, 2026

  • Private placement of shares of common stock and pre-funded warrants

    Jun 24, 2025

    Tranche closed: US$7.1M raised · US$0.1046 a share

    Use of proceeds: General working capital and repayment of certain notes

    Tranche closed Apr 3, 2025 · Tranche closed Jun 24, 2025

Read by 6ix AI from the company's releases

Decks

Ernexa Therapeutics Inc. on 6ix

Sector
Health care
Industry
Biotechnology
News releases
27 in the last 12 months · 72 in all · newest Oct 22, 2026 · oldest 2022
Decks
12 decks · latest Oct 15, 2026

Where Ernexa Therapeutics Inc. is listed

ListingExchangeCountryCurrency
NASDAQ:ERNA · Home listing · This pageNASDAQUnited StatesUSD
BOATS:ERNABOATSUnited StatesUSD

Log in to ask 6ix AI your own questions about Ernexa Therapeutics Inc.